Cargando…

Over-Expression of 60s Ribosomal L23a Is Associated with Cellular Proliferation in SAG Resistant Clinical Isolates of Leishmania donovani

BACKGROUND: Sodium antimony gluconate (SAG) unresponsiveness of Leishmania donovani (Ld) had effectively compromised the chemotherapeutic potential of SAG. 60s ribosomal L23a (60sRL23a), identified as one of the over-expressed protein in different resistant strains of L.donovani as observed with dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Sanchita, Shah, Priyanka, Baharia, Rajendra K., Tandon, Rati, Khare, Prashant, Sundar, Shyam, Sahasrabuddhe, Amogh A., Siddiqi, M. I., Dube, Anuradha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855005/ https://www.ncbi.nlm.nih.gov/pubmed/24340105 http://dx.doi.org/10.1371/journal.pntd.0002527

Ejemplares similares

Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2015)

Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters
por: Baharia, Rajendra K., et al.
Publicado: (2014)

Correction: Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters
por: Baharia, Rajendra K., et al.
Publicado: (2021)

Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani
por: Joshi, Sumit, et al.
Publicado: (2016)

Correction: Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani
por: Joshi, Sumit, et al.
Publicado: (2019)

Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters
por: Kumari, Shraddha, et al.
Publicado: (2012)

Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis
por: Gupta, Reema, et al.
Publicado: (2014)

Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis
por: Kushawaha, Pramod K., et al.
Publicado: (2012)

A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis
por: Ratnapriya, Sneha, et al.
Publicado: (2021)

Th1 Stimulatory Proteins of Leishmania donovani: Comparative Cellular and Protective Responses of rTriose Phosphate Isomerase, rProtein Disulfide Isomerase and rElongation Factor-2 in Combination with rHSP70 against Visceral Leishmaniasis
por: Jaiswal, Anil Kumar, et al.
Publicado: (2014)

Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis
por: Kushawaha, Pramod Kumar, et al.
Publicado: (2012)

Seasonal Variation in the Prevalence of Sand Flies Infected with Leishmania donovani
por: Tiwary, Puja, et al.
Publicado: (2013)

Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology
por: Forgber, Michael, et al.
Publicado: (2006)

Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral Leishmaniasis
por: Kumar, Dinesh, et al.
Publicado: (2013)

Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival
por: Pandey, Rajeev Kumar, et al.
Publicado: (2016)

Role of Efflux Pumps and Intracellular Thiols in Natural Antimony Resistant Isolates of Leishmania donovani
por: Rai, Smita, et al.
Publicado: (2013)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017)

Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India
por: Hasker, Epco, et al.
Publicado: (2013)

LEISHMANIA DONOVANI IN THE PERIPHERAL BLOOD
por: Young, Charles W., et al.
Publicado: (1923)

An Insight Into Systemic Immune Response in Leishmania donovani Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India
por: Thakur, Lovlesh, et al.
Publicado: (2022)

Correction: Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India
por: Hasker, Epco, et al.
Publicado: (2013)

Leishmania actin binds and nicks kDNA as well as inhibits decatenation activity of type II topoisomerase
por: Kapoor, Prabodh, et al.
Publicado: (2010)

SOLiD™ Sequencing of Genomes of Clinical Isolates of Leishmania donovani from India Confirm Leptomonas Co-Infection and Raise Some Key Questions
por: Singh, Neeloo, et al.
Publicado: (2013)

Tissue/Biofluid Specific Molecular Cartography of Leishmania donovani Infected BALB/c Mice: Deciphering Systemic Reprogramming
por: Das, Sanchita, et al.
Publicado: (2021)

Proteomic analysis of the secretome of Leishmania donovani
por: Silverman, J Maxwell, et al.
Publicado: (2008)

Surface antigens of Leishmania donovani promastigotes
Publicado: (1983)

Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012)

Leishmania donovani bodies in bone marrow
por: Ali, Natasha, et al.
Publicado: (2014)

An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1
por: Singh, Neeloo, et al.
Publicado: (2009)

Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients
por: Marlais, Tegwen, et al.
Publicado: (2020)

Ribosome Profiling Reveals HSP90 Inhibitor Effects on Stage-Specific Protein Synthesis in Leishmania donovani
por: Bifeld, Eugenia, et al.
Publicado: (2018)

Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study
por: Gidwani, Kamlesh, et al.
Publicado: (2011)

Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study
por: Ostyn, Bart, et al.
Publicado: (2011)

Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection
por: Mukherjee, Sandip, et al.
Publicado: (2012)

Refinement of Leishmania donovani Genome Annotations in the Light of Ribosome-Protected mRNAs Fragments (Ribo-Seq Data)
por: Sánchez-Salvador, Alejandro, et al.
Publicado: (2023)

Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex
por: Downing, Tim, et al.
Publicado: (2012)

The identification of kala-azar and the discovery of Leishmania donovani.
por: Gibson, M E
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_c3d894jilk13a111tnd12iork7